“This seed funding is critical in enabling our technology to reach its next inflection point, moving our system closer to the clinic and positioning our company for further investment,” said Dr. Mohammad Ali Amini, CEO and Co-Founder of Nanology Labs. “We were fortunate to have been chosen as a finalist in FACIT’s 2018 pitch competition, which helped to strengthen our subsequent application to the Prospects Fund.” As part of FACIT’s suite of commercialization initiatives, investment programs and services, the Prospects Oncology Fund strives to advance Ontario’s cancer research innovations by supporting proof-of-concept activities. The Prospects Fund frequently receives applications from groups who have previously participated in FACIT’s annual Falcons’ Fortunes pitch competition. Any Ontario-based oncology researcher may submit an abstract to the pitch competition. From all abstracts received, six finalists are then invited to pitch their innovations to a diverse panel of expert judges, with the winner receiving the $50,000 Ernsting Entrepreneurship Award. FACIT runs the annual pitch competition as part of its broader mandate to build a culture supportive of entrepreneurship and commercialization in Ontario, generating a source of deal flow and investment opportunities from across the province.